HK1032360A1 - Combination therapy for the treatment of tumors. - Google Patents

Combination therapy for the treatment of tumors.

Info

Publication number
HK1032360A1
HK1032360A1 HK01103128A HK01103128A HK1032360A1 HK 1032360 A1 HK1032360 A1 HK 1032360A1 HK 01103128 A HK01103128 A HK 01103128A HK 01103128 A HK01103128 A HK 01103128A HK 1032360 A1 HK1032360 A1 HK 1032360A1
Authority
HK
Hong Kong
Prior art keywords
combination therapy
tumors
treatment
gastrin
combination
Prior art date
Application number
HK01103128A
Other languages
English (en)
Inventor
Philip C Gevas
Stephen Grimes
Stephen L Karr
Susan A Watson
Dov Michaeli
Original Assignee
Aphton Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corp filed Critical Aphton Corp
Publication of HK1032360A1 publication Critical patent/HK1032360A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK01103128A 1998-05-15 2001-05-03 Combination therapy for the treatment of tumors. HK1032360A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8568798P 1998-05-15 1998-05-15
PCT/US1999/010750 WO1999059628A2 (en) 1998-05-15 1999-05-14 Combination therapy for the treatment of tumors

Publications (1)

Publication Number Publication Date
HK1032360A1 true HK1032360A1 (en) 2001-07-20

Family

ID=22193286

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103128A HK1032360A1 (en) 1998-05-15 2001-05-03 Combination therapy for the treatment of tumors.

Country Status (16)

Country Link
EP (1) EP1076561B1 (xx)
JP (1) JP2002515457A (xx)
KR (1) KR100699574B1 (xx)
CN (1) CN1216605C (xx)
AT (1) ATE291918T1 (xx)
AU (1) AU745749B2 (xx)
CA (1) CA2327439C (xx)
DE (1) DE69924483T2 (xx)
DK (1) DK1076561T3 (xx)
ES (1) ES2237103T3 (xx)
HK (1) HK1032360A1 (xx)
HU (1) HUP0101947A3 (xx)
PL (1) PL193109B1 (xx)
PT (1) PT1076561E (xx)
WO (1) WO1999059628A2 (xx)
ZA (1) ZA200005962B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441228A1 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
CA2450898A1 (en) * 2001-07-09 2003-01-23 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
CN1665487A (zh) * 2002-07-03 2005-09-07 埃弗顿有限公司 脂质体疫苗
JP4689597B2 (ja) 2003-03-28 2011-05-25 レセプター バイオロジックス インク． ガストリンホルモン免疫アッセイ
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
EA017179B1 (ru) * 2011-04-06 2012-10-30 Ооо "Метамакс" Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
EP3071206B1 (en) 2013-11-22 2021-02-17 CL Biosciences LLC Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
DK0380230T3 (da) * 1989-01-24 1995-01-16 Aphton Corp Immunogene sammensætninger mod gastrin-peptider
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17

Also Published As

Publication number Publication date
PT1076561E (pt) 2005-08-31
HUP0101947A3 (en) 2001-12-28
PL344414A1 (en) 2001-11-05
DK1076561T3 (da) 2005-06-06
WO1999059628A3 (en) 2000-01-13
CN1303288A (zh) 2001-07-11
HUP0101947A2 (hu) 2001-11-28
CN1216605C (zh) 2005-08-31
KR100699574B1 (ko) 2007-03-23
AU3904599A (en) 1999-12-06
JP2002515457A (ja) 2002-05-28
CA2327439A1 (en) 1999-11-25
PL193109B1 (pl) 2007-01-31
EP1076561A2 (en) 2001-02-21
WO1999059628A2 (en) 1999-11-25
DE69924483D1 (de) 2005-05-04
KR20010052355A (ko) 2001-06-25
ES2237103T3 (es) 2005-07-16
EP1076561B1 (en) 2005-03-30
AU745749B2 (en) 2002-03-28
DE69924483T2 (de) 2006-02-09
ZA200005962B (en) 2002-01-24
CA2327439C (en) 2005-07-05
ATE291918T1 (de) 2005-04-15

Similar Documents

Publication Publication Date Title
AP9700952A0 (en) Antineoplastic cocoa extracts and method for making and using the same.
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MY113059A (en) Controlled-release dosage forms of azithromycin
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
GR3022321T3 (en) Use of il-4 to treat solid tumors
UA41355C2 (uk) Засіб для лікування нейро-сніду
MY164077A (en) Compositions and uses of et743 for treating cancer
PL344414A1 (en) Combination therapy for the treatment of tumors
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
PT944389E (pt) Composições purificadas de 10-propargil-10-desaza-aminopterina e métodos para a sua utilização no tratamento de tumores
GR3024157T3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
MY121623A (en) Methods of preventing breast cancer.
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
EP1006793A4 (en) COMPOSITIONS FOR TREATING ARRHYTHMIA AND METHODS OF TREATMENT
AP1896A (en) The method of treating cancer
WO1992018536A3 (en) Method for detecting an localizing tissues having neurokinine 1 receptors
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
AU4042795A (en) Treatment of non-small cell lung carcinoma
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IL126158A0 (en) Method for treating substance abuse
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи
UA33715A (uk) Спосіб лікування залізодефіцитних анемій у вагітних
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190513